Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:849-859
Published online before print February 14, 2008, doi: 10.1161/CIRCRESAHA.107.170571
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
102/7/849    most recent
CIRCRESAHA.107.170571v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horsthuis, T.
Right arrow Articles by Christoffels, V. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horsthuis, T.
Right arrow Articles by Christoffels, V. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Diseases
Related Collections
Right arrow Other heart failure
Right arrow Animal models of human disease
Right arrow Hypertrophy
Right arrow Physiological and pathological control of gene expression
Right arrow Cardiac development
(Circulation Research. 2008;102:849.)
© 2008 American Heart Association, Inc.


Molecular Medicine

Distinct Regulation of Developmental and Heart Disease–Induced Atrial Natriuretic Factor Expression by Two Separate Distal Sequences

Thomas Horsthuis, Arjan C. Houweling, Petra E.M.H. Habets, Frederik J. de Lange, Hamid el Azzouzi, Danielle E.W. Clout, Antoon F.M. Moorman, Vincent M. Christoffels

From the Heart Failure Research Center (T.H., A.C.H., P.E.M.H.H, F.J.d.L., D.E.W.C., A.F.M.M., V.M.C.), Academic Medical Center, University of Amsterdam; and the Hubrecht Institute and Interuniversity Cardiology Institute Netherlands (H.e.A.), Royal Netherlands Academy of Sciences, Utrecht, the Netherlands.

Correspondence to Vincent M. Christoffels, Heart Failure Research Center, AMC, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, the Netherlands. E-mail v.m.christoffels{at}amc.uva.nl

Nppa, encoding atrial natriuretic factor, is expressed in fetal atrial and ventricular myocardium and is downregulated in the ventricles after birth. During hypertrophy and heart failure, Nppa expression is reactivated in the ventricles and serves as a highly conserved marker of heart disease. The Nppa promoter has become a frequently used model to study mechanisms of cardiac gene regulation. Nevertheless, the regulatory sequences that provide the correct developmental pattern and ventricular reactivation during cardiac disease remain to be defined. We found that proximal Nppa fragments ranging from 250 bp to 16 kbp provide robust reporter gene activity in the atria and correct repression in the atrioventricular canal and the nodes of the conduction system in vivo. However, depending on fragment size and site of integration into the genome of mice, the fetal ventricular activity was either absent or present in an incorrect pattern. Furthermore, these fragments did not provide ventricular reactivation in heart disease models. These results indicate that the proximal promoter does not provide a physiologically relevant model for ventricular gene activity. In contrast, 2 modified bacterial artificial chromosome clones with partially overlapping genomic Nppa sequences provided appropriate reactivation of the green fluorescent protein reporter during pressure overload–induced hypertrophy and heart failure in vivo. However, only 1 of these bacterial artificial chromosomes provided correct fetal ventricular green fluorescent protein activity. These results show that distinct distal regulatory sequences and divergent regulatory pathways control fetal ventricular activity and reactivation of Nppa during cardiac disease, respectively.


Key Words: Nppa • atrial natriuretic peptide • heart development • hypertrophy • cardiac disease • heart failure




This article has been cited by other articles:


Home page
Circ. Res.Home page
T. Horsthuis, H. P.J. Buermans, J. F. Brons, A. O. Verkerk, M. L. Bakker, V. Wakker, D. E.W. Clout, A. F.M. Moorman, P. A.C. 't Hoen, and V. M. Christoffels
Gene Expression Profiling of the Forming Atrioventricular Node Using a Novel Tbx3-Based Node-Specific Transgenic Reporter
Circ. Res., July 2, 2009; 105(1): 61 - 69.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. T.J. Aanhaanen, J. F. Brons, J. N. Dominguez, M. S. Rana, J. Norden, R. Airik, V. Wakker, C. de Gier-de Vries, N. A. Brown, A. Kispert, et al.
The Tbx2+ Primary Myocardium of the Atrioventricular Canal Forms the Atrioventricular Node and the Base of the Left Ventricle
Circ. Res., June 5, 2009; 104(11): 1267 - 1274.
[Abstract] [Full Text] [PDF]